SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-397661
Filing Date
2014-11-05
Accepted
2014-11-05 10:22:23
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d802835d10q.htm 10-Q 492289
2 EX-10.1 d802835dex101.htm EX-10.1 35332
3 EX-10.2 d802835dex102.htm EX-10.2 34007
4 EX-10.3 d802835dex103.htm EX-10.3 7847
5 EX-31.1 d802835dex311.htm EX-31.1 9464
6 EX-31.2 d802835dex312.htm EX-31.2 9746
7 EX-32.1 d802835dex321.htm EX-32.1 4162
  Complete submission text file 0001193125-14-397661.txt   4911213

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mygn-20140930.xml EX-101.INS 737482
9 XBRL TAXONOMY EXTENSION SCHEMA mygn-20140930.xsd EX-101.SCH 40853
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20140930_cal.xml EX-101.CAL 79418
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20140930_def.xml EX-101.DEF 261967
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20140930_lab.xml EX-101.LAB 351706
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20140930_pre.xml EX-101.PRE 310391
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 141195659
SIC: 2835 In Vitro & In Vivo Diagnostic Substances